Concepedia

LBA9 innovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer

Ignace Vergote, Keiichi Fujiwara, Elsa Kalbacher, Andrea Bagaméri, Sharad Ghamande, J-Y. Lee, Susana Banerjee, Fernando Cotait Maluf, Domenica Lorusso, Kan Yonemori,

Annals of Oncology · 2023 · 30 citations · 0 references

DOIFull text

Open access

Concepts